Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
173.00
+1.00 (0.58%)
Apr 2, 2025, 1:30 PM CST
TPEX:6712 Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Cash & Equivalents | 301.68 | 336.44 | 353.57 | 641.1 | 68.88 | Upgrade
|
Short-Term Investments | 636.5 | 998.6 | 915.99 | 702.6 | 346.1 | Upgrade
|
Cash & Short-Term Investments | 938.18 | 1,335 | 1,270 | 1,344 | 414.98 | Upgrade
|
Cash Growth | -29.73% | 5.16% | -5.52% | 223.80% | -30.15% | Upgrade
|
Accounts Receivable | 193.99 | 100.63 | 84.94 | 33.66 | 15.4 | Upgrade
|
Other Receivables | 7.56 | 0.46 | 0.88 | 29.6 | 2.24 | Upgrade
|
Receivables | 201.54 | 101.09 | 85.82 | 63.27 | 17.63 | Upgrade
|
Inventory | 80.04 | 69.09 | 88.3 | 56.77 | 35.49 | Upgrade
|
Prepaid Expenses | 3.44 | 7.92 | 6.29 | 2.11 | 10.46 | Upgrade
|
Other Current Assets | 0.06 | 7.73 | 5.46 | 0.92 | 0.07 | Upgrade
|
Total Current Assets | 1,223 | 1,521 | 1,455 | 1,467 | 478.63 | Upgrade
|
Property, Plant & Equipment | 48.58 | 64.81 | 89.84 | 125.01 | 171.24 | Upgrade
|
Long-Term Investments | 796.16 | 471.31 | 376.37 | 333.27 | 112.51 | Upgrade
|
Other Intangible Assets | 10.15 | 10.65 | 11.95 | 11.14 | 9.9 | Upgrade
|
Long-Term Deferred Tax Assets | 10.73 | 1.71 | 30.32 | 78.2 | 80.56 | Upgrade
|
Other Long-Term Assets | 47.24 | 6.57 | 9.72 | 8.22 | 5.48 | Upgrade
|
Total Assets | 2,136 | 2,076 | 1,974 | 2,023 | 858.32 | Upgrade
|
Accounts Payable | 25.13 | 23.33 | 29.08 | 15 | 5.04 | Upgrade
|
Accrued Expenses | - | 1.96 | 3.98 | 10.49 | 3.62 | Upgrade
|
Current Portion of Leases | 1.71 | 5.4 | 4.5 | 11.87 | 9.87 | Upgrade
|
Current Income Taxes Payable | 68.07 | 46.76 | 10.47 | 21.04 | - | Upgrade
|
Current Unearned Revenue | 194.13 | 121.65 | 89.89 | 12.22 | 4.12 | Upgrade
|
Other Current Liabilities | 40.05 | 32.55 | 25.82 | 25.9 | 17.67 | Upgrade
|
Total Current Liabilities | 329.09 | 231.64 | 163.74 | 96.51 | 40.32 | Upgrade
|
Long-Term Leases | 1.14 | 0.5 | 13.36 | 22.55 | 33.34 | Upgrade
|
Long-Term Deferred Tax Liabilities | 10.82 | - | 3.59 | 3.82 | 0.05 | Upgrade
|
Other Long-Term Liabilities | 0.78 | 0.82 | 0.76 | 1.96 | 3.86 | Upgrade
|
Total Liabilities | 341.82 | 232.96 | 181.45 | 124.83 | 77.56 | Upgrade
|
Common Stock | 806.73 | 733.39 | 681.4 | 618.18 | 562.89 | Upgrade
|
Additional Paid-In Capital | 551.72 | 785.91 | 872.22 | 1,211 | 486.55 | Upgrade
|
Retained Earnings | 434.23 | 323.67 | 238.51 | 68.74 | -300.86 | Upgrade
|
Comprehensive Income & Other | 1.6 | - | 0.04 | - | 32.19 | Upgrade
|
Shareholders' Equity | 1,794 | 1,843 | 1,792 | 1,898 | 780.76 | Upgrade
|
Total Liabilities & Equity | 2,136 | 2,076 | 1,974 | 2,023 | 858.32 | Upgrade
|
Total Debt | 2.84 | 5.9 | 17.86 | 34.42 | 43.21 | Upgrade
|
Net Cash (Debt) | 935.33 | 1,329 | 1,252 | 1,309 | 371.77 | Upgrade
|
Net Cash Growth | -29.63% | 6.19% | -4.40% | 252.17% | -33.40% | Upgrade
|
Net Cash Per Share | 11.59 | 16.17 | 15.10 | 15.81 | 4.98 | Upgrade
|
Filing Date Shares Outstanding | 80.84 | 80.67 | 82.42 | 82.25 | 74.9 | Upgrade
|
Total Common Shares Outstanding | 80.84 | 80.67 | 82.42 | 82.25 | 74.9 | Upgrade
|
Working Capital | 894.16 | 1,289 | 1,292 | 1,370 | 438.31 | Upgrade
|
Book Value Per Share | 22.20 | 22.84 | 21.74 | 23.07 | 10.42 | Upgrade
|
Tangible Book Value | 1,784 | 1,832 | 1,780 | 1,887 | 770.86 | Upgrade
|
Tangible Book Value Per Share | 22.07 | 22.71 | 21.60 | 22.94 | 10.29 | Upgrade
|
Machinery | - | 91.2 | 85.39 | 82.64 | 104.52 | Upgrade
|
Leasehold Improvements | - | 65.23 | 65.23 | 63.9 | 63.64 | Upgrade
|
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.